Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.2K
Overview
47.2K
Complement System01:27

Complement System

10.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.4K
Physiological Barriers01:25

Physiological Barriers

5.0K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.0K
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

11
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
11
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

1.0K
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
1.0K
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

7.8K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the Effect of Mask Preconditioning With and Without Video Demonstration on Child Induction Behaviour During Inhalational General Anaesthesia: A Randomised Controlled Trial.

Cureus·2025
Same author

Evaluating the therapeutic potential of tofacitinib in Sjögren's disease: a comprehensive clinical and immunological assessment.

Rheumatology (Oxford, England)·2025
Same author

Federated and reusable processing of Earth observation data.

Scientific data·2025
Same author

Metabolic changes during evolution of Sjögren's in both an animal model and human patients.

Heliyon·2025
Same author

Melatonin as a potential adjunct therapy for central nervous system lupus: evidence from the MRL/lpr mouse model.

Precision clinical medicine·2024
Same author

Complement: Functions, location and implications.

Immunology·2023
Same journal

m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma.

Molecular immunology·2026
Same journal

Overexpression of Hes1 inhibits cigarette smoke-induced mitochondrial apoptosis in AT2 cells by activating the Pgc-1α/Tfam signaling pathway.

Molecular immunology·2026
Same journal

Progesterone promotes favorable pregnancy outcomes in recurrent spontaneous, abortion by attenuating NK Cell overactivation and upregulating the cAMP/PKA/CREB signaling axis.

Molecular immunology·2026
Same journal

Oleanolic acid alleviates hepatic fibrosis by inhibiting liver macrophage recruitment and polarization.

Molecular immunology·2026
Same journal

Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury.

Molecular immunology·2026
Same journal

Endothelial-derived TWEAK drives granulosa cell apoptosis in PCOS via the Fn14-oxidative stress axis.

Molecular immunology·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K

Complement and blood-brain barrier integrity.

Alexander Jacob1, Jessy John Alexander1

  • 1Department of Medicine, University at Buffalo, USA.

Molecular Immunology
|July 22, 2014
PubMed
Summary
This summary is machine-generated.

The blood-brain barrier (BBB) becomes leaky during inflammation, disrupting brain function. Targeting C5a/C5aR1 signaling offers a potential therapeutic strategy for neuroinflammatory diseases.

Keywords:
Blood–brain barrierComplementNeurodegeneration

More Related Videos

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels
07:13

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels

Published on: May 7, 2018

9.8K
Isolation of Cerebral Capillaries from Fresh Human Brain Tissue
06:35

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue

Published on: September 12, 2018

12.3K

Related Experiment Videos

Last Updated: Apr 26, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K
A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels
07:13

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels

Published on: May 7, 2018

9.8K
Isolation of Cerebral Capillaries from Fresh Human Brain Tissue
06:35

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue

Published on: September 12, 2018

12.3K

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • The blood-brain barrier (BBB) maintains brain homeostasis but becomes compromised during neuroinflammation.
  • Inflammation disrupts BBB integrity, leading to altered neuronal function.
  • The precise cellular and molecular mediators of BBB dysfunction in inflammation are not fully understood.

Purpose of the Study:

  • To review advances in understanding BBB pathology in neuroinflammation.
  • To highlight the role of complement proteins, particularly C5a/C5aR1 signaling, in BBB dysfunction.
  • To discuss experimental models, technologies, and therapeutic targets.

Main Methods:

  • Review of existing literature on BBB function and neuroinflammation.
  • Focus on studies investigating complement activation pathways (C5a/C5aR1).
  • Analysis of in vivo and in vitro experimental models.

Main Results:

  • C5a signaling via C5aR1 increases BBB permeability in neuroinflammatory settings.
  • C5a/C5aR1 signaling involves the NF-κB pathway and alters microRNA expression in brain endothelial cells.
  • Inhibition or genetic deletion of C5aR1 demonstrates protective effects on the BBB.

Conclusions:

  • C5a/C5aR1 signaling is a key mechanism driving BBB breakdown in neuroinflammation.
  • C5aR1 represents a promising therapeutic target for treating neuroinflammatory diseases.
  • Further research is needed to overcome limitations and fully elucidate BBB pathology mechanisms.